Delivery Order SPE2DB24D1205-SPE2DB25FCZRC
- Not listed
- The Department of Defense Medical Supply Chain awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Skyrizi 360 mg/2.4 mL on-body injectors. This firm fixed-price, non-competitive delivery order is scheduled for completion by August 22, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery supports the federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,830 to AmerisourceBergen Drug Corp for the supply of Skyrizi 360 mg/2.4 mL on-body injectable medication. This firm fixed-price delivery order, issued on July 29, 2025, will be completed by August 19, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award was made through competitive procurement without a set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a $11,830 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 ml on-body injectors on July 29, 2025, with completion targeted for August 19, 2025. This non-set-aside award represents a supply of a specialized biologic medication used primarily for dermatological and rheumatological conditions. The delivery order was issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a $11,830.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 MG/2.4 ML on-body injectors, with an ultimate completion date of September 9, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The pharmaceutical will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 ml on-body injector devices. This firm fixed price delivery order, issued on August 5, 2025, with an ultimate completion date of August 26, 2025, represents a competitive award with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and falls under the company's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of SKYRIZI 360 mg/2.4 mL on-body injectors valued at $11,830.00 under a firm fixed price contract. The order, which is expected to be completed by September 9, 2025, will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded without a set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a $11,830.00 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 180 mg/1.2 ml on-body injectors on July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed price contract represents a competitively awarded, non-set-aside procurement of the pharmaceutical product to support federal medical supply requirements. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $32,614.21 delivery order to AmerisourceBergen Drug Corp for Skyrizi 150 mg/ml pen injectors on August 1, 2025, with an ultimate completion date of August 4, 2025. This non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The pharmaceutical product will...
- The Defense Logistics Agency awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 mL on-body injectors. This firm fixed price, non-competitive delivery order was issued on August 8, 2025, with an ultimate completion date of August 29, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 ml on-body injectors. This firm fixed-price, competitively awarded contract was issued on July 29, 2025, with an ultimate completion date of August 19, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. SKYRIZI is a biologic immunosuppressant medication used in the treatment of moderate-to-severe plaque psoriasis...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCZRCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for the supply of Skyrizi 360 mg/2.4 mL on-body injectors. This firm fixed-price delivery order, issued on August 18, 2025, with an ultimate completion date of September 9, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains. Through this contract vehicle, AmerisourceBergen Drug Corp provides critical medical support to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.8k | 8/18/25 |